• PD98059 (SKU A1663): Precision MEK Inhibition for Reliable C

  2026-05-27

  This article delivers scenario-driven guidance for biomedical researchers using PD98059 (SKU A1663) as a selective MEK inhibitor in cell viability, apoptosis, and neuroprotection assays. Drawing on literature and comparative best practices, it addresses key workflow challenges—ensuring reproducibility, robust interpretation, and vendor reliability, with actionable links to validated resources.

• Optimizing PDGF Inhibition: Practical Scenarios with JNJ-101

  2026-05-27

  This article details scenario-driven best practices for using JNJ-10198409 (SKU C5737) as a robust platelet-derived growth factor receptor inhibitor in cell viability and proliferation assays. Covering experimental design, protocol optimization, and vendor selection, it leverages quantitative data and real-world workflow insights to help researchers achieve reproducible, high-sensitivity results.

• Weight Loss Restores Intestinal Stretch Signaling in Obesity

  2026-05-26

  This study demonstrates that acute intestinal stretch suppresses food intake and improves glucose homeostasis independently of classical incretin signaling, but these effects are blunted in obesity and restored by weight loss. The findings advance understanding of gut mechanosensation in satiety regulation, with implications for metabolic disease research and intervention strategies.

• Sulfo-Cy3 Azide in Neurodevelopment: Enabling Reliable Birth

  2026-05-26

  Explore the transformative role of Sulfo-Cy3 azide as a bioconjugation reagent in neurodevelopmental research, with a focus on precise birthdating of Nurr1-positive neurons and advanced fluorescent microscopy staining. This cornerstone article uniquely connects reagent properties to assay reliability, offering unmatched scientific and practical insights.

• SB203580 in p38 MAPK Signaling: Protocols, Pitfalls, Advance

  2026-05-25

  SB203580 empowers precise dissection of the p38 MAPK pathway, enabling reliable studies in inflammation, neuroprotection, and multidrug resistance reversal. This guide translates cutting-edge research into actionable protocols, highlighting troubleshooting steps and the latest biomaterial innovations for enhanced cell-based assays.

• 3D Spheroid Assay Standardizes Glioblastoma Stemness Detecti

  2026-05-25

  Chen et al. introduce a rapid, reproducible 3D tumor spheroid assay to assess stemness in glioblastoma cell lines. This protocol streamlines workflow, enhances throughput, and enables functional evaluation for drug screening and mechanistic studies.

• PSMD14 Deubiquitinates CARM1 to Drive HCC Progression via FE

  2026-05-24

  This study uncovers a novel oncogenic axis in hepatocellular carcinoma (HCC), revealing that PSMD14-mediated deubiquitination stabilizes CARM1, which in turn activates FERMT1 transcription through H3R17 methylation. These findings highlight the therapeutic potential of targeting the PSMD14–CARM1–FERMT1 pathway in HCC and underscore new opportunities for protease inhibition research in cancer biology.

• M344: Advanced HDAC Inhibition for Neuroblastoma and Epigene

  2026-05-23

  Discover how the histone deacetylase inhibitor M344 enables precise modulation of gene expression, offering new avenues for neuroblastoma research and cell differentiation assays. This article uniquely explores M344’s comparative efficacy and practical assay guidance for cancer and epigenetic studies.

• PD98059 MEK Inhibitor: Protocols and Applied Research Insigh

  2026-05-22

  PD98059 is the gold standard MEK inhibitor for dissecting MAPK/ERK signaling in cell cycle, apoptosis, and neuroprotection studies. Explore optimized workflows, troubleshooting strategies, and translational applications—especially in oxidative stress and hepatotoxicity models—leveraging recent advances and peer-reviewed protocols.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Advan

  2026-05-22

  2,2,2-Trichloroethanol is redefining protein research as a high-purity, workflow-flexible small molecule biochemical. Discover how APExBIO’s reagent optimizes experimental reproducibility and empowers translational advances in molecular biology and cell therapy models.

• Single-Cell Insights into Ciprofloxacin–Tetracycline Antagon

  2026-05-21

  This study pioneers single-cell analysis to unravel the antagonistic interaction between ciprofloxacin hydrochloride and tetracycline, revealing that increased bacterial survival—rather than just slowed growth—underpins the reduced efficacy of their combination. These findings underscore the necessity of single-cell approaches for understanding antibiotic interactions and optimizing therapeutic strategies.

• PAD4-IN-2 TFA: Tumor-Targeted Inhibition of H3 Citrullinatio

  2026-05-21

  PAD4-IN-2 TFA (Compound 5i TFA) leverages meta-phenylboronic acid modification for precise tumor-targeted inhibition of PAD4 activity, reducing histone H3 citrullination and neutrophil extracellular trap formation. Its workflow-friendly selectivity, robust antitumor effects, and proven safety profile make it a standout tool for dissecting the tumor immune microenvironment in advanced cancer models.

• Cy5 NHS ester(Et): Technical Guide for Biomolecule Labeling

  2026-05-20

  Cy5 NHS ester(Et) is a water-soluble fluorescent dye optimized for covalent labeling of primary amines in proteins, peptides, and other biomolecules. It is well-suited for applications such as protein fluorescent labeling, immunofluorescence staining, and flow cytometry, but not for ethanol-based protocols or long-term storage of working solutions. Researchers benefit from its high purity and reliable reactivity when protocols are precisely followed.

• Short-Scale Break-Induced Replication in Mouse Oocytes: Mech

  2026-05-20

  This study reveals that double-strand DNA breaks in fully grown mouse oocytes can trigger short-scale break-induced replication (ssBIR), amplifying DNA damage through mechanisms reliant on Rad51 and DNA replication. The work establishes both the conditions for ssBIR initiation and the inhibitory role of chain-terminating nucleotide analogs like ddATP, opening new avenues for dissecting genome stability in mammalian gametogenesis.

• CCCP in Mitochondrial Dysfunction: Applied Workflows & AI In

  2026-05-19

  Leverage CCCP (carbonyl cyanide m-chlorophenyl hydrazine) for precise disruption of mitochondrial proton gradients in live-cell modeling. Discover how deep learning–powered image analysis transforms Alzheimer’s biomarker discovery and how to optimize your protocols for reproducibility and sensitivity.

456 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page